Xiaobing Jiang

936 total citations · 1 hit paper
35 papers, 598 citations indexed

About

Xiaobing Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaobing Jiang has authored 35 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Xiaobing Jiang's work include Ferroptosis and cancer prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers) and Glioma Diagnosis and Treatment (7 papers). Xiaobing Jiang is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers) and Glioma Diagnosis and Treatment (7 papers). Xiaobing Jiang collaborates with scholars based in China, Singapore and Hong Kong. Xiaobing Jiang's co-authors include Minjie Wang, Jianglin Zheng, Wen Bao, Kai Chen, Xuan Wang, Moxin Wu, Zhipeng Wu, Ling‐Qiang Zhu, Zijie Zhou and Yue Qiu and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaobing Jiang

29 papers receiving 594 citations

Hit Papers

Injectable ultrasonic sensor for wireless monitoring of i... 2024 2026 2025 2024 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Injectable ultrasonic sensor for wireless monitoring of intracranial signals
    2024 104 citations Hanchuan Tang, Yueying Yang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Jiang China 12 326 220 151 87 73 35 598
Huiqin Gao China 13 422 1.3× 189 0.9× 164 1.1× 153 1.8× 49 0.7× 22 837
Zhimin Tang China 13 577 1.8× 216 1.0× 177 1.2× 139 1.6× 63 0.9× 34 965
Liang Xiang China 17 331 1.0× 201 0.9× 89 0.6× 47 0.5× 75 1.0× 64 675
Young-Eun Kim South Korea 11 175 0.5× 118 0.5× 108 0.7× 67 0.8× 59 0.8× 18 492
Shun Xu China 14 504 1.5× 224 1.0× 59 0.4× 49 0.6× 44 0.6× 22 712
Ni Li China 11 268 0.8× 126 0.6× 87 0.6× 53 0.6× 30 0.4× 35 508
Morteza Akbari Iran 16 352 1.1× 205 0.9× 65 0.4× 66 0.8× 216 3.0× 32 710
Zunyi Wang China 10 207 0.6× 129 0.6× 69 0.5× 48 0.6× 94 1.3× 31 503

Countries citing papers authored by Xiaobing Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Jiang more than expected).

Fields of papers citing papers by Xiaobing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Jiang. The network helps show where Xiaobing Jiang may publish in the future.

Co-authorship network of co-authors of Xiaobing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Jiang. A scholar is included among the top collaborators of Xiaobing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Jiang. Xiaobing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shi, Yimin Li, Wenjing Sun, et al.. (2025). Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models. Science Translational Medicine. 17(802). eadq5331–eadq5331.
2.
Huang, Xuemei, Wen Zhao, Yuwen Wang, et al.. (2025). Bioengineering of Heart–Brain Codevelopoid Model Via Trans-Germ-Layer Codevelopment Organoid Chip. Engineering.
3.
Li, Yonghua, Weijie Li, Simin Liu, et al.. (2025). Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. Nature Communications. 17(1). 440–440.
4.
Liu, Zhen, Yihao Wang, Xiaoqing Zeng, et al.. (2025). Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1. Cell Death and Disease. 16(1). 345–345. 2 indexed citations
5.
Tang, Hanchuan, Yueying Yang, Zhen Liu, et al.. (2024). Injectable ultrasonic sensor for wireless monitoring of intracranial signals. Nature. 630(8015). 84–90. 104 indexed citations breakdown →
6.
7.
Duan, Hao, Rong Xiang, Zhenhua Zhang, et al.. (2024). Single-cell atlas profiling revealed cellular characteristics and dynamic changes after PD-1 blockade therapy of brain metastases from laryngeal squamous cell carcinoma. Molecular and Cellular Biochemistry. 480(4). 2377–2400.
8.
9.
Liu, Lingtong, Yingying Cheng, Lin Wu, et al.. (2024). Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade. Toxicology and Applied Pharmacology. 487. 116969–116969. 3 indexed citations
10.
Li, Junjun, Keshan Wang, Chao Yang, et al.. (2023). Tumor‐Associated Macrophage‐Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC‐I Expression. Advanced Science. 10(17). e2207067–e2207067. 55 indexed citations
11.
Zhao, Zhen, Jianglin Zheng, Yi Zhang, et al.. (2023). Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. Journal of Molecular Neuroscience. 73(7-8). 608–627. 1 indexed citations
12.
Zheng, Jianglin, Zijie Zhou, Yue Qiu, et al.. (2022). A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma. SHILAP Revista de lepidopterología. 20 indexed citations
13.
He, Huixia, Ke Wang, Xin Chen, et al.. (2022). EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma. Biomedicine & Pharmacotherapy. 155. 113659–113659. 6 indexed citations
14.
Zheng, Jianglin, Zhipeng Wu, Yue Qiu, Xuan Wang, & Xiaobing Jiang. (2022). An integrative multi-omics analysis based on liquid–liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature. Journal of Translational Medicine. 20(1). 55–55. 13 indexed citations
15.
Li, Xiaoqiang, et al.. (2022). Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3K/AKT pathway. Toxicology and Applied Pharmacology. 451. 116180–116180. 8 indexed citations
16.
Chen, Kai, et al.. (2021). Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease. Frontiers in Cell and Developmental Biology. 9. 704298–704298. 70 indexed citations
17.
Wang, Minjie, et al.. (2021). Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma. Frontiers in Oncology. 11. 650153–650153. 8 indexed citations
18.
Zheng, Jianglin, Zijie Zhou, Yue Qiu, et al.. (2021). A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma. Frontiers in Cell and Developmental Biology. 9. 675555–675555. 58 indexed citations
19.
20.
Bi, Hai-Lian, Xiao‐Yan Bai, Zhaowei Xu, et al.. (2015). DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase. Cell Death and Disease. 6(9). e1891–e1891. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiqin Gao Breakdown of academic impact, for papers by Zhimin Tang Breakdown of academic impact, for papers by Liang Xiang Breakdown of academic impact, for papers by Young-Eun Kim Breakdown of academic impact, for papers by Shun Xu Breakdown of academic impact, for papers by Ni Li Breakdown of academic impact, for papers by Morteza Akbari Breakdown of academic impact, for papers by Zunyi Wang
Rankless by CCL
2026